Cargando…
Treatment of Slow‐Flow After Primary Percutaneous Coronary Intervention With Flow‐Mediated Hyperemia: The Randomized RAIN‐FLOW Study
BACKGROUND: ST‐segment–elevation myocardial infarction complicated with no reflow after primary percutaneous coronary intervention is associated with adverse outcomes. Although several hyperemic drugs have been shown to improve the Thrombolysis in Myocardial Infarction flow, optimal treatment of no...
Autores principales: | Gomez‐Lara, Josep, Gracida, Montserrat, Rivero, Fernando, Gutiérrez‐Barrios, Alejandro, Muntané‐Carol, Guillem, Romaguera, Rafael, Fuentes, Lara, Marcano, Ana, Roura, Gerard, Ferreiro, José Luis, Teruel, Luis, Brugaletta, Salvatore, Alfonso, Fernando, Comín‐Colet, Josep, Gomez‐Hospital, Joan‐Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356082/ https://www.ncbi.nlm.nih.gov/pubmed/37345805 http://dx.doi.org/10.1161/JAHA.123.030285 |
Ejemplares similares
-
Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigation
por: Marcano, Ana Lucrecia, et al.
Publicado: (2022) -
Coronary Endothelium‐Dependent Vasomotor Function After Drug‐Eluting Stent and Bioresorbable Scaffold Implantation
por: Gomez‐Lara, Josep, et al.
Publicado: (2021) -
Síndrome de tako-tsubo asociado con COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020) -
Tako-tsubo syndrome associated with COVID-19
por: Oyarzabal, Loreto, et al.
Publicado: (2020) -
Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19. Respuesta
por: Oyarzabal, Loreto, et al.
Publicado: (2021)